The Use of Model-Based Tumor-Size Metrics to Predict Survival - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Clinical Pharmacology and Therapeutics Année : 2014

The Use of Model-Based Tumor-Size Metrics to Predict Survival

Résumé

Mixed-effect models are increasingly being used to analyze the time-course of tumor size and to identify tumor size metrics as predictors of overall survival in cancer patients. However, caution is needed interpreting the results of such analyses and applying them to clinical research. Sparse individual tumor data as a result of patient mortality can lead to falsely conclusions about tumor size metrics as predictors of overall survival.
Fichier principal
Vignette du fichier
CPT_Ribba_14.pdf (174.65 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

inserm-01084276 , version 1 (18-11-2014)

Identifiants

Citer

Benjamin Ribba, Nick Holford, France Mentré. The Use of Model-Based Tumor-Size Metrics to Predict Survival: Analysis of survival using model-based tumor-size metrics. Clinical Pharmacology and Therapeutics, 2014, 96 (2), pp.133 - 135. ⟨10.1038/clpt.2014.111⟩. ⟨inserm-01084276⟩
306 Consultations
343 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More